# Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction

> **NCT04479917** · PHASE2 · COMPLETED · sponsor: **Vigonvita Life Sciences** · enrollment: 255 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** TPN171H
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04479917
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2021-07-26
- **Final completion:** 2021-07-26
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04479917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04479917, "Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04479917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*